Pramipexole ER vs. Placebo in Fibromyalgia

NCT00689052 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibromyalgia

Interventions

DRUG: pramipexole ER
DRUG: placebo

Sponsor

Boehringer Ingelheim